The reported incidence of PDA varies because of methodological differences related to the
population group studied, age of consideration, and method of detection. 16 Although the …

This review aims to describe the past history, present techniques and future directions in
transcatheter treatment of patent ductus arteriosus (PDA). Transcatheter PDA closure is the …

The American Heart Association makes every effort to avoid any actual or potential conflicts
of interest that may arise as a result of an outside relationship or a personal, professional, or …

Objectives: We sought to analyze safety, efficacy, and follow-up results of percutaneous
closure of perimembranous ventricular septal defects (pmVSD). Background: Results of …

Congenital heart disease is common, occurring in 8 of 1000 live births. 1 With the successes
in cardiothoracic surgery over the past 3 decades and the ongoing improvements in the …

Over the last three decades, knowledge about fundamental and clinical aspects of the
ductus arteriosus has substantially improved, leading to considerable progress in the …

Objectives: To describe case mix variation among institutions, and report adverse event
rates in congenital cardiac catheterization by case type. Background: Reported adverse …

Abstract Background: The National Cardiovascular Data Registry (NCDR) launched the
IMPACT (Improving Pediatric and Adult Congenital Treatment) Registry in 2010. By 2013, its …

OBJECTIVE: Investigate the technical success and safety of percutaneous PDA closure
during infancy. DATA SOURCES: Scopus, Web of Science, Embase, PubMed, and Ovid …

Background Advances in interventional techniques now allow for transcatheter treatment of
some ventricular septal defects (VSD), although there remain concerns about adverse …